Dapsone
Thông số
80-08-0Số CAS
201-248-4Số EC
4-(4-aminophenyl)sulfonylanilineTên IUPAC
C12H12N2O2SCông thức hóa học
248.3 g/molKhối lượng phân tử
dapsone; 80-08-0; 4,4'-Sulfonyldianiline; Diaphenylsulfone; Dapson; 4,4'-Diaminodiphenyl sulfone; 4,4'-Diaminodiphenylsulfone; DADPS; Diphenasone; Novophone; Disulone; Sulfona; Avlosulfone; Croysulfone; Diaphenylsulfon; Avlosulfon; Dumitone; 4-Aminophenyl sulfone; Eporal; Udolac; Bis(4-aminophenyl) sulfone; Dapsonum; Sulfadione; Sulphadione; Aczone; Diphone; p-Aminophenyl sulfone; Metabolite C; Sumicure S; Avlosulphone; Croysulphone; Sulfona-MAE; Diaphenylsulphon; Diaphenylsulphone; 4-(4-aminophenyl)sulfonylaniline; Sulphonyldianiline; Bis(p-aminophenyl) sulfone; Dubronax; Dapsona; Tarimyl; p,p-Sulphonylbisbenzamine; 4,4'-Dapsone; Diaminodiphenyl sulfone; Sulfone ucb; Sulfonyldianiline; p,p-Sulphonylbisbenzenamine; Diaminodiphenylsulfone; 4,4'-Sulfonylbisaniline; p,p'-Diaminodiphenyl sulfone; NSC-6091; Di(4-aminophenyl) sulfone; Benzenamine, 4,4'-sulfonylbis-; p,p-Sulphonyldianiline; Bis(4-aminophenyl)sulfone; Di(p-aminophenyl) sulfone; p,p'-sulfonyldianiline; 4,4'-Sulfonylbisbenzamine; p,p-Sulfonylbisbenzamine; Diaminodifenilsulfona; 4,4'-Sulfonylbisbenzenamine; Di(p-aminophenyl)sulphone; Araldite HT 976; p,p-Sulfonylbisbenzenamine; Bis(p-aminophenyl)sulphone; Di(4-aminophenyl)sulphone; Bis(4-aminophenyl)sulphone; p,p-Diaminodiphenyl sulphone; N,N'-Diphenyl sulfondiamide; Servidapson; 4,4'-Sulphonyldianiline; Di(4-aminophenyl)sulfone; 1,1'-Sulfonylbis(4-aminobenzene); Hardener HT 976; DDS (pharmaceutical); 4,4'-Sulphonylbisbenzamine; 4,4'-Sulphonylbisbenzenamine; 4,4-Diaminodifenylsulfon; 4,4'-Diaminodiphenyl sulphone; Diamino-4,4'-diphenyl sulfone; WR 448; Diamino-4,4'-diphenyl sulphone; DTXSID4020371; NSC 6091D; NCI-C01718; Aniline, 4,4'-sulfonyldi-; 1,1'-Sulphonylbis(4-aminobenzene); 4,4'-Diaminodiphenyl suphone; HT 976; 1358F; 4-(4-aminobenzenesulfonyl)aniline; F 1358; 1,1'-Sulfonylbis[4-aminobenzene]; 4,4'-Sulfonylbisbenzeneamine; HY 976; 4,4'-Sulfonyldianilin; NSC 6091; Sulfone, diphenyl, 4,4'-diamino-; CHEBI:4325; AI3-08087; NSC-6091D; J04BA02; NSC6091; 4-(4-amino-benzenesulfonyl)-phenylamine; DTXCID00371; 8W5C518302; 4-(4-aminophenylsulfonyl)aniline; 4-(4-aminophenylsulfonyl)benzenamine; 4,4'-diaminophenyl sulfone; 4,4' Diaminophenyl Sulfone; Sulfone, 4,4'-Diaminophenyl; Daspone; Undolac; Dapsone Tablets; Dapsone 25 mg; Dapsone 100 mg; Dapsone Gel, 5%; RefChem:5731; 4,4'-sulfonylbis(benzenamine); D10AX05; 201-248-4; DDS, pharmaceutical; DDS; 4-[(4-aminobenzene)sulfonyl]aniline; 4-[(4-aminophenyl)sulfonyl]aniline; MFCD00007887; Diaphenylsulfone (JAN); CHEMBL1043; MLS000069409; Sulfanona-mae; Sulfon-mere; 4,4'-DDS; s4612; NCGC00016322-08; SMR000059064; Sulphon-mere; 4,4'-DIAMINO-15N2-DIPHENYL SULFONE; Dapsonum [INN-Latin]; Dapsona [INN-Spanish]; DSS (VAN); DIAPHENYLSULFONE [JAN]; 4-Aminophenylsulfone; DDS, diaphenylsulfone; Atrisone; Diaminodifenilsulfona [Spanish]; 4,4-Diaminodifenylsulfon [Czech]; 4-[(4-Aminophenyl)sulfonyl]phenylamine; CAS-80-08-0; CCRIS 192; Dapsone (USP); Aczone (TN); 4,4'-diamino diphenyl sulphone; HSDB 5073; 4,4'-Sulfonyldianiline (Dapsone); 4,4'-Diaminodiphenyl Sulfone pound DDS pound(c); SR-01000002976; EINECS 201-248-4; (4-sulfanilylphenyl)amine; BRN 0788055; Diaphenyl sulfone; Dapsone [USAN:USP:INN:BAN]; Dapsone RS; Dapsone CRS; UNII-8W5C518302; Prestwick_152; ALBB-005917; Dapsone (Standard); IN-201; 4,4''-dapsone; Spectrum_000888; DAPSONE [VANDF]; Aniline,4'-sulfonyldi-; DAPSONE [HSDB]; DAPSONE [IARC]; DAPSONE [USAN]; DAPSONE [INN]; DAPSONE [MI]; DAPSONE [MART.]; Opera_ID_1950; Prestwick0_000035; Prestwick1_000035; Prestwick2_000035; Prestwick3_000035; Spectrum2_001133; Spectrum3_000375; Spectrum4_000310; Spectrum5_000825; WLN: ZR DSWR DZ; 4,4''-sulfonyldianiline; DAPSONE [USP-RS]; DAPSONE [WHO-DD]; DAPSONE [WHO-IP]; 4,4''-sulfonylbisaniline; 4'-Diaminodiphenyl sulfone; Epitope ID:766884; EC 201-248-4; 4,4'-Sulfonyldiphenylamine; Benzenamine,4'-sulfonylbis-; Oprea1_143052; SCHEMBL21428; BSPBio_000129; BSPBio_002129; CBDivE_013582; Dianiline, 4,4'-sulfonyl-; KBioGR_000900; KBioSS_001368; MLS001055349; MLS001076146; 4,4''-Sulfonylbisbenzenamine; 4,4'-Sulfonylbis[benzamine]; 4-Aminophenyl sulfone, 97%; BIDD:GT0770; DAPSONE [EP IMPURITY]; DAPSONE [ORANGE BOOK]; DivK1c_000573; p,p''-diaminodiphenyl sulfone; SPECTRUM1500222; SPBio_001025; SPBio_002050; DAPSONE [EP MONOGRAPH]; 4,4''-diaminodiphenyl sulfone; 4,4'-diamino diphenyl sulfone; BPBio1_000143; orb1223974; orb1310195; orb3139509; SCHEMBL1219599; DAPSONE [USP MONOGRAPH]; DAPSONUM [WHO-IP LATIN]; GTPL10934; HMS501M15; HY-B0688R; KBio1_000573; KBio2_001368; KBio2_003936; KBio2_006504; KBio3_001349; MSK7106; NINDS_000573; HMS1568G11; HMS1920C14; HMS2091K04; HMS2095G11; HMS2231G09; HMS3259C13; HMS3369B11; HMS3712G11; HMS5083H21; HMS6018G07; Pharmakon1600-01500222; Dapson 100 microg/mL in Methanol; HY-B0688; 1,1''-sulfonylbis(4-aminobenzene); Tox21_110371; Tox21_201347; Tox21_300558; BBL002412; BDBM50029764; CCG-40260; EBC-03730; MSK7106-100M; NSC756716; SBB003168; STK387118; AKOS000119322; MSK7106-1000M; Tox21_110371_1; DB00250; FD20798; HT 9664; KS-1450; NC00488; NSC-756716; IDI1_000573; Dapsone Solution in Methanol, 100ug/mL; NCGC00016322-01; NCGC00016322-02; NCGC00016322-03; NCGC00016322-04; NCGC00016322-05; NCGC00016322-06; NCGC00016322-07; NCGC00016322-09; NCGC00016322-10; NCGC00016322-12; NCGC00016322-13; NCGC00023946-03; NCGC00023946-04; NCGC00023946-05; NCGC00023946-06; NCGC00254533-01; NCGC00258899-01; Sulphadione,4,4'-sulfonylbisbenzeneamine; AC-10922; 4-[(4-Aminophenyl)sulfonyl]phenylamine #; Dapsone Solution in Methanol, 1000ug/mL; SBI-0051331.P003; DB-056406; AB00051962; D0089; Dapsone, VETRANAL(TM), analytical standard; NS00000683; ST50308134; T0891; EN300-19042; C07666; D00592; H23984; AB00051962_19; F358228; Q422226; SR-01000002976-2; SR-01000002976-4; BRD-K62363391-001-05-8; BRD-K62363391-001-15-7; BRD-K62363391-001-24-9; SULFACETAMIDE SODIUM IMPURITY D [EP IMPURITY]; Dapsone, British Pharmacopoeia (BP) Reference Standard; Dapsone, European Pharmacopoeia (EP) Reference Standard; F0266-3067; Z104472374; Dapsone, United States Pharmacopeia (USP) Reference Standard; Dapsone, Pharmaceutical Secondary Standard; Certified Reference MaterialTên gọi khác
